Navigation Links
FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Date:9/19/2011

Serious skin infections, as well as infections of the abdomen, urinary tract and ear, were more frequent in patients treated with Prolia. Patients should be advised to seek prompt medical attention if they develop signs or symptoms of severe infection, including cellulitis. Endocarditis was reported more frequently in the Prolia-treated patient group. Epidermal and dermal adverse events such as dermatitis, rashes and eczema have been reported. Discontinuation of Prolia should be considered if severe symptoms develop.

In clinical trials in women with postmenopausal osteoporosis, Prolia resulted in significant suppression of bone remodeling. The significance of these findings is unknown. The long-term consequences of the degree of suppression of bone remodeling observed with Prolia may contribute to adverse outcomes such as osteonecrosis of the jaw (ONJ), atypical fractures and delayed fracture healing. ONJ has been reported in patients with Prolia. Patients should be monitored for these adverse outcomes.

The most common adverse reactions (> 5 percent and more common than placebo) in patients with postmenopausal osteoporosis were back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia and cystitis. Pancreatitis has also been reported. The most common (per patient incidence > 10 percent) adverse reactions reported with Prolia in patients with bone loss receiving androgen deprivation therapy for prostate cancer or adjuvant aromatase inhibitor therapy for breast cancer are arthralgia and back pain.  Pain in extremity and musculoskeletal pain have also been reported in clinical trials.  

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics.  A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient.  Amgen th
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... -- The Society of Corporate Compliance and Ethics ... 4,500 compliance and ethics professionals from across industry, ... fines and settlements.  The SCALENDAR is designed to ... reference to demonstrate to employees the consequences of ... help compliance and ethics officers looking for a ...
(Date:9/15/2014)... , Sept. 15, 2014 Research and ... "Closed Drug Transfer Systems to 2020" report to ... deemed hazardous to humans has been receiving increasing amounts ... these substances become more clearly understood. For caregivers and ... forefront of attempts to mitigate exposure to cytotoxic drugs ...
(Date:9/15/2014)... Sept. 15, 2014 Sysmex America, a ... systems technology, announced today an amended distributorship agreement ... for Sysmex reagents, controls and instruments including the ... ™ , Sysmex XP-300™, XT-Series and XN-Series Automated ... effective immediately and continues until August 31, 2017.  ...
Breaking Medicine Technology:More than $55 billion in fines and settlements added by SCCE to its 2015 Corporate Scandal Calendar 2Closed Drug Transfer Systems to 2020 2Closed Drug Transfer Systems to 2020 3Sysmex America, Inc. Renews LABSCO Distributorship 2Sysmex America, Inc. Renews LABSCO Distributorship 3
(Date:9/15/2014)... HealthDay Reporter MONDAY, Sept. ... twice as often as they,re actually needed for children ... More than 11 million antibiotic prescriptions written each ... to researchers from University of Washington and Seattle Children,s ... eradicate children,s viral illnesses, researchers said, but supports the ...
(Date:9/15/2014)... -- Births of multiple babies cost more and pose ... researchers report. The researchers suggest that limiting embryo ... ease some of that burden. Over the past ... births to older mothers and use of assisted reproductive ... South Wales, Australia. Their study, published online Sept. ...
(Date:9/15/2014)... PA (PRWEB) September 15, 2014 ... private insurance exchange technology, today announced that ... insurance organization in southeastern Pennsylvania, has selected the ... private health insurance exchange marketplace for employers with ... provided by Array Spectrum™, Independence will offer employer ...
(Date:9/15/2014)... New York (PRWEB) September 15, 2014 ... in U.S. courts, Bernstein Liebhard LLP notes that a ... be useful in curbing aggression in children with ADHD ... and parent training in behavioral management techniques. According to ... children with ADHD and aggression problems, half of whom ...
(Date:9/15/2014)... had a heart attack are at greater risk of death ... is missed, according to a new study. Researchers ... of their treatment early on, such as an electrocardiogram within ... steps in their care later on. The researchers added, however, ... all nine steps critical to their care are followed. , ...
Breaking Medicine News(10 mins):Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 2Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 3Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 2Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 3Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 4Health News:Heart Attack Patients Face Greater Death Risk if Any Treatment Step Missed: Study 2
... can bring relief to people who snore and suffer from sleep ... The device is named as 'aveoTSD' and is the result of ... related to a range of problems from high blood pressure and ... by snoring partners. , ,The device is like using a ...
... Researchers from Slovenia had been able to unravel the ... the August issue of CHEST, the peer-reviewed journal of ... study of 40 patients, researchers used CT scan imaging ... structures responsible for snoring. ,Based on questionnaires ...
... Philadelphia, Aug 15. The best single predictor of happiness ... marital status only follow health as per a recent ... and graduate student Laura Tach from Harvard University measured ... 20-to-64-year-olds using analysis from the 1972-2002 General Social Survey. ...
... does not discriminate between rich and poor, if ... celebrities have succumbed to it and some have ... these famous// actresses and personalities who have suffered ... and Singer,Shirley Temple Black - Actress/singer/diplomat,Jill Eikenberry, Actress,Nancy ...
... differs in their ability to exercise for better physical ... that an enzyme involved in blood pressure regulation may ... findings, by researchers at Wake Forest University School of ... of the American Medical Association., ,The study is ...
... leading cause of blindness that affects millions of people ... Taking vitamin E supplements, as well as a higher ... , could slow cataract progression. , ,Although surgical ... researchers say they are investigating whether dietary changes can ...
Cached Medicine News:Health News:Rich are happier then Poor 2Health News:Gene Decides How Much Exercise In Needed For The Elderly People 2
Revised Drug calibrator that replaces existing Drug calibrator - this product contains Lithium in addition to Digoxin, Phenobarbital, OPhenytoin, & Theophulline....
... goal is to provide state-of-the-art rapid diagnostic ... Each year millions of people around the ... detection or undetected disease and illness. Diseases ... developing, manufacturing and marketing our tests to ...
Agglutination test on slide for qualitative and quantitative determination of Syphilis in serum or plasma....
... as a quality assurance reagent ... to Toxoplasma gondii (TOXO IgG), ... (rubella IgG), IgG antibody to ... antibody to herpes simplex virus ...
Medicine Products: